Rona Harmelin-Kadouri

Rona Harmelin-Kadouri currently serves as Vice President and Head of Global Clinical Operations at BioNTech SE since September 2022, following a role as Vice President of Operational Transformation. Prior experience includes positions at Bristol Myers Squibb, where Rona held the title of Executive Director for Global Clinical Trial Strategy & Operations and Senior Director of Clinical Operations for Cell Therapy. Previous roles also span leadership positions at Celgene, Merck, Schering-Plough Research Institute, Columbia University, Dartmouth Medical School, and GlaxoSmithKline. Rona's educational background includes an MSc in Epidemiology and Preventive Medicine from Tel Aviv University and a BSc in Clinical Nutrition from The Hebrew University of Jerusalem.